Sign Up to like & get
recommendations!
1
Published in 2019 at "Molecular pharmaceutics"
DOI: 10.1021/acs.molpharmaceut.9b00808
Abstract: C-X-C chemokine receptor type 4 (CXCR4) is overexpressed in hematological and solid malignancies. LY2510924 is a potent peptide antagonist of CXCR4. A derivative of LY2510924, BL01, was evaluated for theranostic applications targeting CXCR4. METHODS BL01…
read more here.
Keywords:
177lu bl01;
bl01;
68ga bl01;
68ga 177lu ... See more keywords